Health Stream Analytics, LLC advises health systems, device makers, and digital-health teams on fetal/maternal signal processing, predictive EMR analytics, and the translation of physiological data into deployed clinical AI.
Deep specialty expertise, two ways to engage.
Strategy and technical diligence for digital-health ventures and investors: model validation, regulatory pathway framing, and signal-processing architecture review.
ECG, EEG, HRV and autonomic biomarkers, and real-time pipelines from raw waveform to clinical decision support — with deep roots in fetal/maternal monitoring.
Causal inference and outcome prediction on clinical EHR data — from phenotyping to deployable models for risk stratification and earlier warning across care settings.
Study design, biomarker discovery, and rigorous clinical validation — grounded in 20+ years of physiological and neuroscience research and 120+ peer-reviewed publications.
Physician-scientist leadership.
Health Stream Analytics, LLC is led by Martin G. Frasch, MD, PhD, a physician-scientist with 20+ years in perinatal health research and 120+ publications spanning fetal neurophysiology, autonomic biomarkers, and clinical machine learning — including foundational work on fetal EEG monitoring (US Patent 9,215,999 B2). HSA brings that depth to ventures, device makers, and health systems building the next generation of healthcare AI.
Whether you're an investor needing technical diligence, a device maker validating signals, or a team building healthcare AI — we'd like to hear what you're working on.